D-0165-2023 Class II Terminated
FDA drug recall D-0165-2023 was initiated by Amerisource Health Services LLC on Dec 20, 2022 and is designated Class II. Reason for recall: Failed Impurities/Degradations Specifications The recall status is terminated (terminated Sep 6, 2024). Affected quantity: 3,091 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 25, 2023
- Initiation Date
- Dec 20, 2022
- Termination Date
- Sep 6, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,091 cartons
Product Description
Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11)
Reason for Recall
Failed Impurities/Degradations Specifications
Distribution Pattern
Nationwide in the USA.
Code Information
Lot #: 1007805, exp. 12/31/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0165-2023
- openFDA file date
- Oct 21, 2026
- Loaded by RegDataLab
- Oct 23, 2026